NIH-funded research NIH-funded research

Creating new methods to build carbon-carbon bonds for drug development

Official title: Exploiting Interfacial Design for the Electrocatalytic Construction of C-C bonds

Funded at University of Chicago · NIH-11082388 · Data updated 2026-11-12

This study is exploring a new way to create important ingredients for medicines using electricity, which could make it easier and faster to produce complex drugs that help people.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startAugust 1, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$385,136
NIH project number5R35GM150845-03
Project IDNIH-11082388 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include individuals requiring new or improved medications for various diseases.

Less likely to help

Patients who are not seeking new drug therapies or those with conditions that do not require pharmaceutical intervention may not benefit from this research.

What this research studies

This research aims to innovate drug discovery by developing a new synthetic platform that utilizes electricity to drive organic transformations. It focuses on coupling various organic halides with aldehydes and ketones to create carbon-carbon bonds with high selectivity. By optimizing the interactions between the electrode material and the electrophiles, the research seeks to produce new chiral alcohols and derivatives that are important in pharmaceuticals. This approach could simplify the synthesis of complex drugs, making them more accessible and efficient to produce.

Why it matters

Potential benefit: If successful, this research could lead to more efficient and cost-effective methods for producing essential pharmaceuticals.

How similar studies have gone: Other research has shown promise in using electrocatalytic methods for organic synthesis, indicating potential for success in this novel approach.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Wuttig, Anna — University of Chicago
  • Study coordinator: Wuttig, Anna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.